News

News

The technology behind Meatable's cultured meat sausage is bit.bio’s opti-ox

bit.bio CEO and founder welcomes Meatable's cultured meat sausage, powered by opti-ox.

21.07.2022

Published by bit.bio

bit.bio CEO and founder welcomes Meatable's cultured meat sausage, powered by opti-ox.

Published by bit.bio

Read now

News

Q&A with our Head of Phenotyping

Dr Davide Danovi talks to The Academy of Medical Sciences as a FLIER participant in cross-sector leadership programme.

20.10.2021

Published by Academy of Medical Sciences

Read now

News

Former CEO Mark Kotter speaks at TEDxCambridgeUniversity

bit.bio CEO spoke about reprogramming human cells at the TEDxCambridgeUniversity ‘Untangling networks’ event.

26.03.2021

Published by bit.bio

Read now

News

Cultivated meat and cell therapies opti-ox™ technology underpins both

Today Meatable announced their Series A fundraise of $47 million. Read about the connection to bit.bio.

23.03.2021

Published by bit.bio

Read now

ioHepatocytes